Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net income	$ 56,126	$ 44,681
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,764	1,378
Change in deferred income taxes	(1,043)	7,960
Change in payable to related parties pursuant to tax receivable agreement	0	(539)
Equity-based compensation	1,897	2,341
Equity in loss (income) of investees	625	(20,049)
Fair value adjustment of other investments	(4,344)	(3,455)
Proceeds received from investments	3,343	3,381
Non-cash lease expense	1,374	3,522
Other	14	(849)
Changes in operating assets and liabilities:
Fees receivable	6,887	155
Prepaid expenses	283	177
Due from related parties	(1,908)	136
Other assets	1,128	(1,613)
Accounts payable	743	976
Accrued compensation and benefits	16,807	2,189
Lease liability	(1,819)	771
Other liabilities	(18,241)	(10,917)
Consolidated variable interest entities related:
Net cash provided by operating activities	60,952	32,389
Investing activities:
Purchase of furniture, fixtures and equipment	(1,707)	(4,535)
Purchase of other investments	(20,236)	(298)
Cash paid for acquisition of business	(1,500)	(10,096)
Distribution from investment valued under the measurement alternative	0	12,739
Distributions received from investments	2,227	13,281
Contributions to investments	(35,237)	(15,522)
Net cash used in investing activities	(56,453)	(4,431)
Financing activities:
Borrowings of debt	25,000	0
Repayments of debt	(457)	(469)
Draw-down on revolver	25,000	0
Repayment of revolver	0	(15,000)
Repurchase of Class A shares for employee tax withholding	0	(68)
Proceeds received from issuance of shares under Employee Share Purchase Plan	485	397
Dividends paid	(12,947)	(11,201)
Members’ distributions paid	(30,485)	(15,809)
Other	0	(74)
Consolidated variable interest entities related:
Net cash provided by (used in) financing activities	6,496	(42,087)
Increase (decrease) in cash, cash equivalents, and restricted cash	10,995	(14,129)
Cash, cash equivalents, and restricted cash at beginning of the period	76,197	90,377
Cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities at end of the period	87,192	76,248
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Total cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities	87,192	76,248
Consolidated Entity Excluding Variable Interest Entities (VIE)
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	83,052	73,124
Restricted cash	3,996	3,048
Primary Beneficiary
Adjustments to reconcile net income to net cash provided by operating activities:
Fair value adjustment of other investments	(1,966)	2,244
Consolidated variable interest entities related:
Change in warrant liability measured at fair value	(1,966)	2,244
Equity in income of investees	(732)	(229)
Other assets and liabilities	14	129
Consolidated variable interest entities related:
Contributions from non-controlling interest in general partnerships	133	232
Distributions to non-controlling interest in general partnerships	(233)	(95)
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	144	$ 76
Restricted cash	$ 276,083